Envestnet Asset Management
GMAB icon

Envestnet Asset Management’s Genmab GMAB Stock Holding History

Envestnet Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8M Sell
829,687
-32,614
-4% -$867K 0.01% 1353
2026
Q1 		$23.1M Buy
862,301
+55,666
+7% +$1.67M 0.01% 1251
2025
Q4 		$24.8M Sell
806,635
-3,304
-0.4% -$103K 0.01% 1084
2025
Q3 		$24.8M Buy
809,939
+60,336
+8% +$1.47M 0.01% 1139
2025
Q2 		$15.5M Buy
749,603
+13,277
+2% +$273K ﹤0.01% 1419
2025
Q1 		$14.4M Buy
736,326
+12,545
+2% +$263K ﹤0.01% 1409
2024
Q4 		$15.1M Sell
723,781
-319,779
-31% -$7.03M ﹤0.01% 1364
2024
Q3 		$25.4M Buy
1,043,560
+47,893
+5% +$1.28M 0.01% 1041
2024
Q2 		$25M Sell
995,667
-26,463
-3% -$750K 0.01% 999
2024
Q1 		$30.6M Buy
1,022,130
+96,212
+10% +$2.83M 0.01% 880
2023
Q4 		$29.5M Sell
925,918
-20,962
-2% -$658K 0.01% 837
2023
Q3 		$33.4M Buy
946,880
+457,772
+94% +$17.4M 0.02% 733
2023
Q2 		$18.6M Sell
489,108
-620,763
-56% -$24.7M 0.01% 964
2023
Q1 		$16.9M Buy
1,109,871
+585,924
+112% +$22.5M 0.01% 969
2022
Q4 		$22.2M Buy
523,947
+17,483
+3% +$720K 0.01% 806
2022
Q3 		$16.3M Buy
506,464
+136,616
+37% +$4.8M 0.01% 885
2022
Q2 		$12M Sell
369,848
-52,895
-13% -$1.71M 0.01% 1051
2022
Q1 		$15.3M Sell
422,743
-37,180
-8% -$1.28M 0.01% 984
2021
Q4 		$18.2M Buy
459,923
+30,852
+7% +$1.29M 0.01% 887
2021
Q3 		$18.8M Sell
429,071
-160,740
-27% -$7.22M 0.01% 823
2021
Q2 		$24.1M Buy
589,811
+27,470
+5% +$1.06M 0.01% 716
2021
Q1 		$18.5M Buy
562,341
+95,820
+21% +$3.6M 0.01% 744
2020
Q4 		$19M Buy
466,521
+236,741
+103% +$8.85M 0.01% 638
2020
Q3 		$8.41M Buy
229,780
+55,268
+32% +$2M 0.01% 891
2020
Q2 		$5.91M Buy
174,512
+14,463
+9% +$394K 0.01% 1043
2020
Q1 		$3.39M Buy
160,049
+21,946
+16% +$489K ﹤0.01% 1180
2019
Q4 		$3.08M Buy
138,103
+4,952
+4% +$108K ﹤0.01% 1377
2019
Q3 		$2.7M Buy
+133,151
New +$2.62M ﹤0.01% 1384

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management's GMAB Position: Q2 2026 in Review

Envestnet Asset Management reduced its Genmab (GMAB) stake by 3.8% in Q2 2026, selling an estimated $867K and leaving 829,687 shares worth $22.8M. The position accounts for 0.01% of the portfolio, ranked #1353.

Envestnet Asset Management first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $33.4M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Envestnet Asset Management held 829,687 shares of Genmab worth $22.8M as of Q2 2026.
  • Envestnet Asset Management sold 32,614 Genmab shares in Q2 2026, an estimated $867K.
  • Genmab made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1353 holding.
  • Envestnet Asset Management first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • Envestnet Asset Management's Genmab position peaked at $33.4M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.